CLOSE X

RK Global

MISSED CALL NO 7412074708
Search
Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE5246.7582.75 (+1.6 %)
PREV CLOSE ( ) 5164.00
OPEN PRICE ( ) 5396.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 52430
TODAY'S LOW / HIGH ( )5223.50 5396.20
52 WK LOW / HIGH ( )4701 5933
NSE5246.0073.5 (+1.42 %)
PREV CLOSE( ) 5172.50
OPEN PRICE ( ) 5278.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 145626
TODAY'S LOW / HIGH( ) 5214.50 5295.50
52 WK LOW / HIGH ( )4700.65 5933.5
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 08-08 1973
Management Info
Basudeo N Singh - Chairman Sandeep Singh - Managing Director
Registered Office

Address Alkem House,Senapati Bapat Marg,Lower Parel (West),
Mumbai,
Maharashtra-400013

Phone 022 3982 9999

Email investors@alkem.com / contact@alkem.com

Website www.alkemlabs.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
07Apr Alkem Laboratories launches everyday m
Alkem Laboratories has launched A to Z Daily, an everyday multivitamin s..
31Mar Alkem Laboratories incorporates subsid
Alkem Laboratories has incorporated a wholly owned subsidiary (WOS) as a..
23Mar Alkem Laboratories launches semaglutid
Alkem Laboratories has launched semaglutide injection in India under the..
21Mar Alkem Laboratories informs about updat
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
21Mar Alkem Laboratories informs about press
Alkem Laboratories has informed that it enclosed Press release on Alkem..
MORE
Financials
in Crores
QTR Dec 25 ANNUAL 25
Net Profit622.142280.89
Gross Profit 706.15 2303.54
Operating Profit 820.742663.26
Net Sales 2491.278813.44
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
up  14050.60 (6.72%)
M.Cap ( in Cr)18026.76
Abbott India (BSE)
up  25853.30 (0.75%)
M.Cap ( in Cr)54936.46
Acutaas Chemicals (BSE)
up  2341.10 (5.98%)
M.Cap ( in Cr)19166.85
NGL Fine-Chem (BSE)
up  2337.00 (5.67%)
M.Cap ( in Cr)1443.80
Astrazeneca Pharma I (BSE)
up  7890.95 (1.48%)
M.Cap ( in Cr)19727.38
MORE
Shareholding Pattern
PROMOTERS 51.2%
NON-INSTITUTION 17.3%
MUTUAL FUNDS/UTI 16.06%
FI/BANKS/INSURANCE 3.96%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
Scheme NameHold(%)
Tata Nifty MidSmall Healthcare Index Fund-Reg(G)4.49
Motilal Oswal Nifty MidSmall Healthcare Index Fund-Reg(G)4.47
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)4.01
NJ ELSS Tax Saver Scheme-Reg(G)3.58
LIC MF Healthcare Fund-Reg(G)3.50
ICICI Pru Nifty Pharma Index Fund-Reg(G)3.36
Nippon India Nifty Pharma ETF3.36
MORE
Call Us +91 -33 40142930
Email Us care.kolkata@rkglobal.in
Corporate Office Flat No.5 Sagar Apartment 6 Tilak Marg, New Delhi 110 001
Attention Investors

Prevent unauthorised Transactions in your account —> Update your mobile numbers/email 10s with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...... Issued in the interest of Investors Prevent Unauthorized Transactions in your demat account—> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day Issued in the interest of investors. No need to issue cheques by investor while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of

KYC

KYC KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DR Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Compliance Officer : Mr. Kamesh Gupta. 011-43100999. kgupta@rkglobal.in / grievances@rkglobal.in - File a Complaint on SCORES

Registration Nos : SEBI Registration No . INZ000187132; Research Regn. No. : INH000002210; IN-DP-241-2016; NSDL: DP ID - IN 302453 (Delhi), IN 302951 (Kolkata); R K Global Shares & Securities Ltd CIN NO:U99999MH1995PTC174185;

Filing Complaints on SCORES - Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID. Benefits: Effective Communication, Speedy redressal of the grievances.

Company
Quick LInks

Copyrights 2020 © rkglobal.in - All Right Reserved

Designed,Developed & Content Powered by Accord Fintech Pvt Ltd.